Effects of Mediyoga in Patients With Paroxysmal Atrial Fibrillation

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01789372

Enrollment

Registered

2013-02-12

Start date

2009-12-31

Completion date

2012-06-30

Last updated

2013-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paroxysmal Atrial Fibrillation

Keywords

paroxysmal atrial fibrillation, yoga, quality of life, blood pressure, heart rate, heart rate variability

Brief summary

The purpose of this study is to determinate if mediyoga has effects in quality of life, heart rate variability, blood pressure , heart rate in patients with paroxysmal atrial fibrillation (PAF).

Detailed description

This is randomized prospective pilot study. Eighty patients from Danderyd hospital, Stockholm, Sweden were randomized to either mediyoga group or control group. The mediyoga group were completing yoga for one hour, once a week for 12 weeks together with usual treatment. The controlgroup had only usual treatment.The usual treatment consists of pharmaceutical, cardio version and ablation. Quality of life ( SF-36, EQ-5d), blood pressure, heart rate and 24-hours ekokardiografi were measured at baseline and after twelve weeks.A follow up after six months was accomplished with SF-36 and EQ-5d, bloodpressure and heart rate.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Diagnosis of PAF

Exclusion criteria

* The exclusions criteria were multiple concurrent medical conditions and/or cognitive dysfunction (in the diagnosis of e.g. mental illness), considered not to be able to carry out yoga owing to ability to move and those who have difficulties to understand the Swedish language.

Design outcomes

Primary

Measure	Time frame
Quality of life	Change from baseline in SF-36 after 12 weeks.Change from baseline in SF-36 after six months.

Secondary

Measure	Time frame
Blood pressure	Change from baseline in blood pressure after 12 weeks. Change from baseline in blood pressure after six months
heart rate	Change from baseline in heart rate after 12 weeks.Change from baseline in heart rate after six months.
Heart variability	Change from baseline in heart variability after 12 weeks.Change from baseline in heart variability after six months.

Countries

Sweden

Outcome results